Policy | September 14, 2023
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Meningitis still affects more than 2.5 million people globally each year
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Subscribe To Our Newsletter & Stay Updated
